Skip to main content
. 2024 Mar 25;6(7):101072. doi: 10.1016/j.jhepr.2024.101072

Fig. 1.

Fig. 1

Flow chart of the study cohort.

BOC, boceprevir; GT, genotype; IFN, interferon; P/R, pegylated interferon/ribavirin; SOF, sofosbuvir; RBV, ribavirin; TVR, telaprevir. ∗also includes patients who were treated other DAAs from clinical studies, ∗∗only in patients with GT1.